RXRA_HUMAN - dbPTM
RXRA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RXRA_HUMAN
UniProt AC P19793
Protein Name Retinoic acid receptor RXR-alpha
Gene Name RXRA
Organism Homo sapiens (Human).
Sequence Length 462
Subcellular Localization Nucleus .
Protein Description Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes..
Protein Sequence MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHICAICGDRSSGKHYGVYSCEGCKGFFKRTVRKDLTYTCRDNKDCLIDKRQRNRCQYCRYQKCLAMGMKREAVQEERQRGKDRNENEVESTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Sumoylation----MDTKHFLPLDF
----CCCCCCCCCCC
28.2628112733
12PhosphorylationHFLPLDFSTQVNSSL
CCCCCCCCCCCCCCC
20.0023090842
13PhosphorylationFLPLDFSTQVNSSLT
CCCCCCCCCCCCCCC
36.2123663014
17PhosphorylationDFSTQVNSSLTSPTG
CCCCCCCCCCCCCCC
28.0623663014
18PhosphorylationFSTQVNSSLTSPTGR
CCCCCCCCCCCCCCC
30.3923663014
20PhosphorylationTQVNSSLTSPTGRGS
CCCCCCCCCCCCCCC
34.3130266825
21PhosphorylationQVNSSLTSPTGRGSM
CCCCCCCCCCCCCCC
26.2630266825
23PhosphorylationNSSLTSPTGRGSMAA
CCCCCCCCCCCCCCC
39.0030266825
27PhosphorylationTSPTGRGSMAAPSLH
CCCCCCCCCCCCCCC
12.1411162439
32PhosphorylationRGSMAAPSLHPSLGP
CCCCCCCCCCCCCCC
34.2816184197
49PhosphorylationGSPGQLHSPISTLSS
CCCCCCCCCCHHCCC
32.30-
56PhosphorylationSPISTLSSPINGMGP
CCCHHCCCCCCCCCC
32.67-
66PhosphorylationNGMGPPFSVISSPMG
CCCCCCCEEEECCCC
25.06-
70PhosphorylationPPFSVISSPMGPHSM
CCCEEEECCCCCCCC
14.05-
78PhosphorylationPMGPHSMSVPTTPTL
CCCCCCCCCCCCCCC
28.14-
82PhosphorylationHSMSVPTTPTLGFST
CCCCCCCCCCCCCCC
14.2720432439
108SumoylationVSSSEDIKPPLGLNG
CCCCCCCCCCCCCCC
53.5616912044
108SumoylationVSSSEDIKPPLGLNG
CCCCCCCCCCCCCCC
53.56-
124PhosphorylationLKVPAHPSGNMASFT
EEECCCCCCCHHHHH
32.6928555341
129PhosphorylationHPSGNMASFTKHICA
CCCCCHHHHHHEEEH
23.7623917254
145AcetylationCGDRSSGKHYGVYSC
CCCCCCCCEEEEEEC
35.2817761950
147PhosphorylationDRSSGKHYGVYSCEG
CCCCCCEEEEEECCC
16.27-
150PhosphorylationSGKHYGVYSCEGCKG
CCCEEEEEECCCCCC
11.8428152594
151PhosphorylationGKHYGVYSCEGCKGF
CCEEEEEECCCCCCH
11.8628152594
222PhosphorylationRNENEVESTSSANED
CCCCCCCCCCCCCCC
38.4720873877
223PhosphorylationNENEVESTSSANEDM
CCCCCCCCCCCCCCC
17.1320873877
224PhosphorylationENEVESTSSANEDMP
CCCCCCCCCCCCCCC
36.4120873877
225PhosphorylationNEVESTSSANEDMPV
CCCCCCCCCCCCCCH
34.8920873877
246PhosphorylationELAVEPKTETYVEAN
EEECCCCCCEEEEEC
44.2529449344
248PhosphorylationAVEPKTETYVEANMG
ECCCCCCEEEEECCC
37.7929449344
249PhosphorylationVEPKTETYVEANMGL
CCCCCCEEEEECCCC
7.0520432439
259PhosphorylationANMGLNPSSPNDPVT
ECCCCCCCCCCCHHH
58.3026657352
259UbiquitinationANMGLNPSSPNDPVT
ECCCCCCCCCCCHHH
58.30-
260PhosphorylationNMGLNPSSPNDPVTN
CCCCCCCCCCCHHHH
29.0430278072
266PhosphorylationSSPNDPVTNICQAAD
CCCCCHHHHHHHHHH
25.0128450419
267UbiquitinationSPNDPVTNICQAADK
CCCCHHHHHHHHHHH
33.02-
320UbiquitinationFSHRSIAVKDGILLA
CCCCCEEEECCEEEE
5.75-
356UbiquitinationVLTELVSKMRDMQMD
HHHHHHHHHHHCCCC
30.40-
364UbiquitinationMRDMQMDKTELGCLR
HHHCCCCHHHHHCEE
38.26-
397PhosphorylationEALREKVYASLEAYC
HHHHHHHHHHHHHHH
11.09-
403PhosphorylationVYASLEAYCKHKYPE
HHHHHHHHHHCCCCC
7.83-
417UbiquitinationEQPGRFAKLLLRLPA
CCCCHHHHHHHHHHH
36.63-
417AcetylationEQPGRFAKLLLRLPA
CCCCHHHHHHHHHHH
36.6325953088

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
27SPhosphorylationKinasePRKACAP17612
GPS
49SPhosphorylationKinaseGSK3BP49841
PSP
56SPhosphorylationKinaseMAPK8P45983
Uniprot
56SPhosphorylationKinaseMAPK9P45984
Uniprot
66SPhosphorylationKinaseGSK3BP49841
PSP
70SPhosphorylationKinaseMAPK8P45983
Uniprot
70SPhosphorylationKinaseMAPK9P45984
Uniprot
78SPhosphorylationKinaseGSK3BP49841
PSP
82TPhosphorylationKinaseMAPK_GROUP-PhosphoELM
82TPhosphorylationKinaseMAPK8P45983
Uniprot
82TPhosphorylationKinaseMAPK9P45984
Uniprot
82TPhosphorylationKinaseMAPK-FAMILY-GPS
249YPhosphorylationKinaseMAP2K4P45985
GPS
260SPhosphorylationKinaseMAPK_GROUP-PhosphoELM
260SPhosphorylationKinaseMAPK-FAMILY-GPS
260SPhosphorylationKinaseJNK2P45984
PSP
260SPhosphorylationKinaseJNK1P45983
PSP
260SPhosphorylationKinaseMAPK3P27361
GPS
260SPhosphorylationKinaseMAPK1P28482
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
21SPhosphorylation

11162439
27SPhosphorylation

11162439
56SPhosphorylation

11162439
70SPhosphorylation

11162439
82TPhosphorylation

11162439
260SPhosphorylation

11162439

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RXRA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BRD8_HUMANBRD8physical
10517671
CTNB1_HUMANCTNNB1physical
12771132
RNF8_HUMANRNF8physical
14981089
NR4A1_HUMANNR4A1physical
14980220
HDAC3_HUMANHDAC3physical
12943985
HDAC4_HUMANHDAC4physical
12943985
RARA_HUMANRARAphysical
12052862
MYOD1_HUMANMYOD1physical
9692544
TADA3_HUMANTADA3physical
12235159
NR1H4_HUMANNR1H4physical
7760852
NR1H2_HUMANNR1H2physical
7760852
NCOA6_HUMANNCOA6physical
11773444
NR2F6_HUMANNR2F6physical
10318855
NR1H3_HUMANNR1H3physical
8621574
PARP1_RATParp1physical
10082530
PRGC1_HUMANPPARGC1Aphysical
11714715
NRIP1_HUMANNRIP1physical
8887632
SP1_HUMANSP1physical
10361124
PPARG_HUMANPPARGphysical
7838715
CENPR_HUMANITGB3BPphysical
10490654
NPAS2_HUMANNPAS2physical
11439184
CLOCK_HUMANCLOCKphysical
11439184
BMAL1_HUMANARNTLphysical
11439184
NR1I3_HUMANNR1I3physical
8114692
TIF1A_HUMANTRIM24physical
11851396
NCOA2_HUMANNCOA2physical
11851396
NCOA3_HUMANNCOA3physical
11851396
VDR_HUMANVDRphysical
9632709
NCOA2_MOUSENcoa2physical
11514567
SNW1_HUMANSNW1physical
11514567
NCOA2_HUMANNCOA2physical
11514567
THB_HUMANTHRBphysical
9171239
NCOA1_HUMANNCOA1physical
9171239
IBP3_HUMANIGFBP3physical
10874028
THB_HUMANTHRBphysical
19211732
VDR_HUMANVDRphysical
16357103
NCOA3_HUMANNCOA3physical
15863722
MED1_HUMANMED1physical
15863722
RPB1_HUMANPOLR2Aphysical
15863722
SMCA4_HUMANSMARCA4physical
15774904
NCOA2_HUMANNCOA2physical
15657427
VDR_HUMANVDRphysical
15647825
VDR_HUMANVDRphysical
11149488
VDR_HUMANVDRphysical
11075811
NCOA1_HUMANNCOA1physical
11027271
NCOA3_HUMANNCOA3physical
11027271
GRIP1_HUMANGRIP1physical
11027271
MED1_HUMANMED1physical
11027271
NCOA1_HUMANNCOA1physical
10935544
VDR_HUMANVDRphysical
10733574
VDR_HUMANVDRphysical
10037600
VDR_HUMANVDRphysical
14726489
CTCF_HUMANCTCFphysical
20404925
VDR_HUMANVDRphysical
20564192
KIF1A_HUMANKIF1Aphysical
15604093
PRS8_HUMANPSMC5physical
8598193
TIF1A_HUMANTRIM24physical
8598193
NCOA3_HUMANNCOA3physical
9346901
TRI32_HUMANTRIM32physical
21984809
NR4A1_HUMANNR4A1physical
17761950
EP300_HUMANEP300physical
17761950
NR4A1_HUMANNR4A1genetic
17761950
VDR_HUMANVDRphysical
11124027
NCOR1_HUMANNCOR1physical
11124027
NCOA1_HUMANNCOA1physical
11124027
BHE40_HUMANBHLHE40physical
19786558
BHE41_HUMANBHLHE41physical
19786558
ARI5A_HUMANARID5Aphysical
15941852
PRS8_HUMANPSMC5physical
8603043
NCOA2_HUMANNCOA2physical
9430642
VDR_HUMANVDRphysical
12847098
CHD9_HUMANCHD9physical
16554032
STAT1_HUMANSTAT1physical
21988832
VDR_HUMANVDRphysical
21988832
NCOA4_HUMANNCOA4physical
10347167
LX15B_HUMANALOX15Bphysical
15698583
NCOA1_HUMANNCOA1physical
23975195
PPARA_HUMANPPARAphysical
23711995
PPARG_HUMANPPARGphysical
23711995
NCOR1_HUMANNCOR1physical
11903058
RARA_HUMANRARAphysical
21478865
VDR_HUMANVDRphysical
21478865
PPARG_HUMANPPARGphysical
14587029
PPARG_HUMANPPARGphysical
17312272
PPARG_HUMANPPARGphysical
18217139
RXRA_HUMANRXRAphysical
25795708
NCOA1_HUMANNCOA1physical
10454579
TRIP4_HUMANTRIP4physical
10454579
RARA_HUMANRARAphysical
7705655
NCOA1_HUMANNCOA1physical
11438648
MED1_HUMANMED1physical
11438648
GRIP1_MOUSEGrip1physical
11438648
SRF_HUMANSRFphysical
11641790
RXRA_HUMANRXRAphysical
9121466
NCOA1_HUMANNCOA1physical
9121466
RARA_HUMANRARAphysical
25241761
CTNB1_HUMANCTNNB1physical
25241761
TF65_HUMANRELAphysical
25241761
ZBT16_HUMANZBTB16physical
25241761
KLF5_HUMANKLF5physical
16224062
RARA_HUMANRARAphysical
16224062
TRAF2_HUMANTRAF2physical
25795708
TF65_HUMANRELAphysical
16608838
P85A_HUMANPIK3R1physical
20541701
NR1I2_HUMANNR1I2physical
22976785
VDR_HUMANVDRphysical
26329759

Drug and Disease Associations
Kegg Disease
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
DrugBank
DB00459Acitretin
DB00210Adapalene
DB00523Alitretinoin
DB00307Bexarotene
DB00749Etodolac
Regulatory Network of RXRA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Serine 27, a human retinoid X receptor alpha residue, phosphorylatedby protein kinase A is essential for cyclicAMP-mediated downregulationof RXRalpha function.";
Harish S., Ashok M.S., Khanam T., Rangarajan P.N.;
Biochem. Biophys. Res. Commun. 279:853-857(2000).
Cited for: PHOSPHORYLATION AT SER-27, FUNCTION, AND MUTAGENESIS OF SER-27.
Sumoylation
ReferencePubMed
"Negative modulation of RXRalpha transcriptional activity by smallubiquitin-related modifier (SUMO) modification and its reversal bySUMO-specific protease SUSP1.";
Choi S.J., Chung S.S., Rho E.J., Lee H.W., Lee M.H., Choi H.S.,Seol J.H., Baek S.H., Bang O.S., Chung C.H.;
J. Biol. Chem. 281:30669-30677(2006).
Cited for: SUMOYLATION AT LYS-108, AND INTERACTION WITH SENP6.

TOP